Guotai CSI All Share Communication Equipment ETF(515880) Rises 2.60%, Aiming for Sixth Consecutive Gain
NewTimeSpace News, as of 13:29 on May 13, 2026, Guotai Communications ETF (515880) rose 2.60%, aiming for a sixth consecutive gain. The latest quoted price is 1.54 yuan. Looking at a longer timeframe, as of May 12, 2026, Guotai Communications ETF gained 13.63% over the past week. (The stocks listed above are merely index constituents and do not constitute any specific recommendation.)
In terms of liquidity, Guotai Communications ETF recorded an intraday turnover rate of 7.12%, with a trading volume of 1.996 billion yuan. Over a longer horizon, as of May 12, the ETF's average daily turnover over the past week stood at 2.805 billion yuan.
Regarding scale, the latest AUM of Guotai Communications ETF reached 27.870 billion yuan, hitting a one-year high. (Data source: Wind)
In terms of share size, the latest share count of Guotai Communications ETF reached 18.552 billion units, hitting a one-year high. (Data source: Wind)
From a net capital inflow perspective, Guotai Communications ETF experienced continuous net inflows for eight consecutive days, with the highest single-day net inflow of 570 million yuan, totaling an inflow of 2.091 billion yuan, and an average daily net inflow of 261 million yuan. (Data source: Wind)
Data shows that leveraged funds continue to position themselves. The latest margin purchase amount for Guotai Communications ETF reached 196 million yuan, and the latest margin balance stood at 879 million yuan. (Data source: Wind)
As of May 12, Guotai Communications ETF's net value increased by 399.21% over the past five years, ranking 3rd out of 1,200 equity index funds, placing it in the top 0.25%. In terms of return capability, as of May 12, 2026, since its inception, the ETF achieved a highest single-month return of 45.44%, a longest consecutive gaining streak of six months with a cumulative gain of 133.31%, a ratio of up months to down months of 44:36, an average return of 8.55% during up months, an annual positive return rate of 66.67%, and a historical two-year holding period profitability probability of 65.27%. As of May 12, 2026, the ETF's annualized excess return over its benchmark over the past two years was 1.20%.
As of May 8, 2026, Guotai Communications ETF's one-year Sharpe ratio was 3.50.
In terms of drawdown, as of May 12, 2026, Guotai Communications ETF's maximum drawdown since the beginning of the year was 8.16%, with a relative drawdown versus its benchmark of 0.41%. The number of days to recover after drawdown was 22 days.
In terms of fees, Guotai Communications ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%.
In terms of tracking accuracy, as of May 12, 2026, Guotai Communications ETF's three-month tracking error was 0.020%.
Guotai Communications ETF closely tracks the CSI All-Share Communications Equipment Index. The CSI All-Share Communications Equipment Index selects listed company securities whose businesses involve the communications equipment sector from the CSI All-Share Index as index constituents, in order to reflect the overall performance of listed company securities in this theme.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- POU SHENG INT'L(03813.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 183.32 million, YoY increase of 32.49%
- YUE YUEN IND(00551.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at USD 35.18 million, YoY decrease of 53.56%
- TCL ELECTRONICS(01070.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at HKD 359.34 million, YoY increase of 123.63%
- Henlius (02696.HK): HLX48 (EGFR/c-MET Dual-target ADC) Secures Australian Approval for Phase I Clinical Trial
- Henlius (02696.HK): HLX97 (KAT6A/B Inhibitor) Completes First Patient Dosing in Phase I Clinical Trial for Advanced Solid Tumors